LayerBio
Home Cataracts OcuRing™ Technology News & Events
HomeCataractsOcuRing™ TechnologyNews & Events
LayerBio
LayerBio CEO Presents at American Academy of Ophthalmology
Kenneth MandellNovember 3, 2023
LayerBio Presents at the American Society for Cataract and Refractive Surgery
Kenneth MandellApril 25, 2022
LayerBio's CEO presents at Eyecelerator at ASCRS 2022
Kenneth MandellApril 21, 2022
LayerBio wins Best Pitch at Octane's Ophthalmology Tech Summit
Kenneth MandellJuly 9, 2021
LayerBio CEO Presents OcuRing-K™ at OIS Anterior Innovation Showcase
Kenneth MandellApril 9, 2021
LayerBio's CEO Gives Keynote at Drug Delivery Summit
Kenneth MandellMarch 16, 2021
LayerBio's CEO Dr. Ken Mandell Featured in OIS Podcast
Kenneth MandellJuly 30, 2020
LayerBio Awarded $3M from U.S. Department of Defense (DoD) to Advance OcuRing™ for Cataract Surgery
Kenneth MandellJuly 1, 2020
LayerBio Awarded $1.2 Million from NIH to Develop Sustained-Release Glaucoma Drug
Kenneth MandellMay 8, 2018
LayerBio to Present Preclinical Results for Extended Release Glaucoma Formulation at ARVO
Kenneth MandellApril 28, 2018
Dr. Paula Hammond, LayerBio Founding Scientist, gives a TED talk on using nanotechnology to fight cancer
Vicente CasellasApril 6, 2016
LayerBio to present at The Massachusetts Technology Transfer Center (MATTO) New Ventures Showcase in Boston on November 16th
Vicente CasellasNovember 9, 2015
LayerBio receives Milestone Achievement Program grant through the Massachusetts Life Sciences Center
Kenneth MandellMay 26, 2015
LayerBio awarded Small Business Innovative Research (SBIR) grant from the National Institute of Health to develop a drug-eluting intraocular lens for cataract
Vicente CasellasDecember 18, 2014
LayerBio awarded Small Business Innovative Research (SBIR) grant from the National Science Foundation to develop its sustained-release glaucoma product
Vicente CasellasDecember 11, 2014
LayerBio CEO Presents Strategy to Develop a Sustained-Release Glaucoma Product at MIT VMS Demo Day 2014
Vicente CasellasApril 30, 2014
LayerBio, Inc. Announces Launch; Signs Option for Technology from MIT New Drug Delivery Company to Focus on Ophthalmology and Wound Care
Vicente CasellasNovember 13, 2013
LayerBio
info@layerbio.com
Hours